Research & Development
20 November 2026 - Ophthalmic pharmaceutical company Tenpoint Therapeutics Ltd announced on Friday a New Drug Submission to Health Canada seeking approval of YUVEZZI (carbachol and brimonidine tartrat...
20 November 2026 - Luminopia Inc, a digital health company developing a new class of treatments for neuro-visual disorders, announced on Thursday that it has been named a Winner at the 2026 Digital He...
20 November 2026 - Interlude Biopharma Co, a late-stage, drug-development company focused on celiac disease, announced on Thursday the company's public launch at the 21st International Celiac Dis...
19 November 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Thursday that it has received European Commission approval for VaxRabeo, its next-generation rab...
19 November 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced late Wednesday that it has received US Food and Drug Administration (FDA) approval for Infilbray (v...
18 November 2026 - Ichnos Glenmark Innovation Inc (IGI), a clinical-stage biotechnology company focused on developing Multispecific therapeutics in oncology, announced on Tuesday the submission of an ...